This Diagnostic Testing Company Down 60% – Time to Buy?

Despite witnessing double-digit revenue growth in the last reported quarter Natera Inc. (NTRA) stock has plunged nearly 60% year-to-date. So, let’s evaluate if it is worth buying the stock now….

Leave a comment

Your email address will not be published. Required fields are marked *